The University of Chicago Header Logo

Connection

Anjana Pillai to Bevacizumab

Back to Details
This is a "connection" page, showing publications Anjana Pillai has written about Bevacizumab.
Anjana Pillai
Connection Strength
0.271
Bevacizumab
  1. Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future. Hepatol Commun. 2024 06 01; 8(6).
    View in: PubMed
    Score: 0.216
  2. Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction. JAMA Oncol. 2024 Sep 01; 10(9):1253-1258.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.